全文获取类型
收费全文 | 4909篇 |
免费 | 382篇 |
国内免费 | 16篇 |
专业分类
耳鼻咽喉 | 54篇 |
儿科学 | 121篇 |
妇产科学 | 118篇 |
基础医学 | 798篇 |
口腔科学 | 78篇 |
临床医学 | 519篇 |
内科学 | 1090篇 |
皮肤病学 | 46篇 |
神经病学 | 449篇 |
特种医学 | 225篇 |
外国民族医学 | 26篇 |
外科学 | 599篇 |
综合类 | 32篇 |
一般理论 | 1篇 |
预防医学 | 370篇 |
眼科学 | 85篇 |
药学 | 331篇 |
中国医学 | 16篇 |
肿瘤学 | 349篇 |
出版年
2023年 | 29篇 |
2022年 | 66篇 |
2021年 | 141篇 |
2020年 | 79篇 |
2019年 | 123篇 |
2018年 | 168篇 |
2017年 | 115篇 |
2016年 | 116篇 |
2015年 | 126篇 |
2014年 | 171篇 |
2013年 | 241篇 |
2012年 | 377篇 |
2011年 | 381篇 |
2010年 | 236篇 |
2009年 | 177篇 |
2008年 | 309篇 |
2007年 | 309篇 |
2006年 | 295篇 |
2005年 | 271篇 |
2004年 | 242篇 |
2003年 | 241篇 |
2002年 | 200篇 |
2001年 | 75篇 |
2000年 | 78篇 |
1999年 | 72篇 |
1998年 | 35篇 |
1997年 | 26篇 |
1996年 | 22篇 |
1995年 | 26篇 |
1994年 | 17篇 |
1993年 | 26篇 |
1992年 | 52篇 |
1991年 | 42篇 |
1990年 | 33篇 |
1989年 | 47篇 |
1988年 | 20篇 |
1987年 | 42篇 |
1986年 | 44篇 |
1985年 | 24篇 |
1984年 | 21篇 |
1983年 | 15篇 |
1981年 | 9篇 |
1979年 | 14篇 |
1975年 | 12篇 |
1974年 | 18篇 |
1973年 | 12篇 |
1972年 | 14篇 |
1971年 | 12篇 |
1970年 | 10篇 |
1969年 | 14篇 |
排序方式: 共有5307条查询结果,搜索用时 15 毫秒
81.
82.
83.
Fábio Teixeira Kuhn Fabíola Trevizol Verônica Tironi Dias Raquel Cristine Silva Barcelos Camila Simonetti Pase Karine Roversi Caren Tatiane de David Antoniazzi Katiane Roversi Nardeli Boufleur Dalila Moter Benvegnú Tatiana Emanuelli Marilise Escobar Bürger 《Toxicology letters》2015
Chronic consumption of processed food causes structural changes in membrane phospholipids, affecting brain neurotransmission. Here we evaluated noxious influences of dietary fats over two generations of rats on amphetamine (AMPH)-conditioned place preference (CPP). Female rats received soybean oil (SO, rich in n-6 fatty acids (FA)), fish oil (FO, rich in n-3 FA) and hydrogenated vegetable fat (HVF, rich in trans fatty acids (TFA)) for two successive generations. Male pups from the 2nd generation were maintained on the same supplementation until 41 days of age, when they were conditioned with AMPH in CPP. While the FO group showed higher incorporation of n-3 polyunsaturated-FA (PUFA) in cortex/hippocampus, the HVF group showed TFA incorporation in these same brain areas. The SO and HVF groups showed AMPH-preference and anxiety-like symptoms during abstinence. Higher levels of protein carbonyl (PC) and lower levels of non-protein thiols (NPSH) were observed in cortex/hippocampus of the HVF group, indicating antioxidant defense system impairment. In contrast, the FO group showed no drug-preference and lower PC levels in cortex. Cortical PC was positively correlated with n-6/n-3 PUFA ratio, locomotion and anxiety-like behavior, and hippocampal PC was positively correlated with AMPH-preference, reinforcing connections between oxidative damage and AMPH-induced preference/abstinence behaviors. As brain incorporation of trans and n-6 PUFA modifies its physiological functions, it may facilitate drug addiction. 相似文献
84.
Singh Jasvinder A. Richards John S. Chang Elizabeth Toupin-April Karine Barton Jennifer L. 《Clinical rheumatology》2021,40(2):693-700
Clinical Rheumatology - To assess rheumatologists’ views and practices related to shared decision-making (SDM) in gout treatment. We performed a cross-sectional electronic survey of... 相似文献
85.
Carine Couzigou Michel Daudon Jean Luc Meynard Fran?oise Borsa-Lebas Denise Higueret Lélia Escaut David Zucman Jean-Yves Liotier Jean-Louis Quencez Karine Asselah Thierry May Didier Neau Daniel Vittecoq 《Clinical infectious diseases》2007,45(8):e105-e108
Among protease inhibitors, atazanavir has not been associated with urolithiasis in clinical studies. We describe 11 cases of atazanavir-associated urolithiasis in patients with human immunodeficiency virus (HIV) infection. Patients with low water intake, high urinary pH, and a prior history of urinary stones may have a higher risk of atazanavir-associated urine crystallization. 相似文献
86.
87.
Vasopeptidase inhibition with omapatrilat in chronic heart failure: acute and long-term hemodynamic and neurohumoral effects 总被引:1,自引:0,他引:1
McClean DR Ikram H Mehta S Heywood JT Rousseau MF Niederman AL Sequeira RF Fleck E Singh SN Coutu B Hanrath P Komajda M Bryson CC Qian C Hanyok JJ;Omapatrilat Hemodynamic Study Group 《Journal of the American College of Cardiology》2002,39(12):2034-2041
OBJECTIVES: We investigated the acute and long-term hemodynamic and neurohumoral effects of the vasopeptidase inhibitor omapatrilat in human heart failure. BACKGROUND: Angiotensin-converting enzyme (ACE) inhibition constitutes a major advance in the treatment of chronic heart failure (CHF). Simultaneous inhibition of both neutral endopeptidase and ACE with omapatrilat may represent a new treatment strategy in CHF. METHODS: Three hundred and sixty-nine patients with symptomatic heart failure were randomized to double-blind treatment with omapatrilat (first 190 patients: 2.5 mg, 5 mg or 10 mg; last 179 patients: 2.5 mg, 20 mg or 40 mg once daily) for 12 weeks. RESULTS: Acutely, the 10 mg, 20 mg and 40 mg doses of omapatrilat produced greater reductions in pulmonary capillary wedge pressure (PCWP), systolic blood pressure (SBP) and systemic vascular resistance compared with 2.5 mg. Higher doses were associated with greater increases in vasodilator and natriuretic peptides, in addition to ACE inhibition. After 12 weeks, omapatrilat 20 mg and 40 mg showed greater falls from baseline in PCWP (40 mg: 0 h to 12 h average change -7.3 +/- 0.8 mm Hg) and SBP (40 mg: -11.7 +/- 1.7 mm Hg) than 2.5 mg (both p < 0.01 vs. 2.5 mg). The incidence of adverse experiences and patient withdrawal were similar in all groups. CONCLUSIONS: In CHF, the acute hemodynamic benefit seen with higher doses of omapatrilat was associated with increases in plasma vasodilator and natriuretic peptide levels in addition to ACE inhibition. After 12 weeks, the hemodynamic benefit was maintained. Omapatrilat may be a promising new agent in CHF. 相似文献
88.
MacDonald TM Reginster JY Littlejohn TW Richard D Lheritier K Krammer G Rebuli R 《Journal of hypertension》2008,26(8):1695-1702
OBJECTIVES: Nonsteroidal anti-inflammatory drugs vary in their impact on blood pressure and the effect of lumiracoxib 100 mg once daily has not been studied previously. To examine whether lumiracoxib 100 mg once daily would result in lower 24-h mean systolic ambulatory blood pressure than ibuprofen 600 mg three times daily in osteoarthritis patients with controlled hypertension, a 4-week, randomized, double-blind, parallel-group study was conducted in 79 centres in nine countries. METHODS: Hypertensive osteoarthritis patients of 50 years at least whose office blood pressure was less than 140/90 mmHg on stable antihypertensive treatment were randomized to lumiracoxib (n = 394) 100 mg once daily or ibuprofen 600 mg three times daily (n = 393) and 24-h ambulatory blood pressure monitoring was performed at baseline and end of study. The primary outcome measure was a comparison of the change in 24-h mean systolic ambulatory blood pressure from baseline to week 4. Secondary analyses included other blood pressure-related endpoints and efficacy (pain) measurements. RESULTS: Compared with baseline, the 24-h mean systolic ambulatory blood pressure (least square mean) decreased in lumiracoxib-treated patients (-2.7 mmHg) and increased in ibuprofen-treated patients (+2.2 mmHg) at 4 weeks, estimated difference -5.0 mmHg (95% confidence interval -6.1 to -3.8) in favour of lumiracoxib. The 24-h mean diastolic ambulatory blood pressure changes were -1.5 mmHg (lumiracoxib), +0.5 mmHg (ibuprofen), difference -2.0 mmHg (95% confidence interval -2.7 to -1.3). Efficacy results were comparable. CONCLUSIONS: Treatment with lumiracoxib 100 mg once daily resulted in clinically significant lower blood pressure compared with ibuprofen 600 mg three times daily in osteoarthritis patients with well controlled hypertension. 相似文献
89.
Nahon S Lahmek P Lesgourgues B Nahon-Uzan K Tuszynski T Traissac L Delas N 《The American journal of gastroenterology》2002,97(3):590-593
OBJECTIVES: GI blood loss is the most common cause of iron deficiency anemia (IDA) in postmenopausal women and menstrual blood loss in premenopausal women. We aimed to evaluate the diagnostic yield of endoscopy in women with IDA and to define predictive factors of a GI lesion. METHOD: Clinical, biological, endoscopic, and histological data from patients with IDA were systematically collected on a computer. Multivariate analysis (logistic regression) was performed to determine whether these data were associated with a GI lesion. RESULTS: Between January, 1989 and June, 1999, 241 consecutive women had endoscopies for IDA (mean age = 52.3 +/- 21.8 yr). A substantial GI lesion was detected in 119 patients (49.4%). Ten patients (4%) had both upper and lower GI lesions. A source of IDA was revealed by upper endoscopy in 86 cases (35.6%) and by colonoscopy in 33 (13.7%). The most common upper lesions were peptic ulceration (42/241 [17.4%]), esophagitis (15/241 [6.2%]), and cancer (9/241 [3.7%]). Colonic cancer (15/241 [6.2%]) and polyps (10/241 [4.1%]) were the most frequent lesions detected by colonoscopy. Predictive factors (odds ratio, 95% CI) of GI lesions diagnosed by endoscopy were abdominal symptoms (8.3, 3.9-17.2), age > 50 yr (4.4, 2.1-9.2), and Hb < 9 g/dl (3, 1.5-6.1). Thirty-one women (13%) had none of these predictive factors; in this group only two lesions were identified (one esophagitis and one duodenal ulcer). The positive predictive value of these three independent predictors was 87%, and the negative predictive value was 93.5%. CONCLUSION: Endoscopy revealed a source of IDA in 49.4% of cases. Three predictive factors of GI lesion were identified. Endoscopic investigation should be avoided in women without these three predictive factors. Conversely, these factors are strongly associated with a GI lesion. 相似文献
90.
David Eric Ouedraogo Alain Makinson Nils Kuster Nicolas Nagot Pierre-Alain Rubbo Karine Bollore Vincent Foulongne Guillaume Cartron Daniel Olive Jacques Reynes Jean-Pierre Vendrell Edouard Tuaillon 《Journal of clinical immunology》2013,33(1):22-29